BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: David KL, Best RG, Brenman LM, Bush L, Deignan JL, Flannery D, Hoffman JD, Holm I, Miller DT, O'Leary J, Pyeritz RE; ACMG Social Ethical Legal Issues Committee. Patient re-contact after revision of genomic test results: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2019;21:769-71. [PMID: 30578420 DOI: 10.1038/s41436-018-0391-z] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 11.3] [Reference Citation Analysis]
Number Citing Articles
1 Sawyer L, Creswick H, Lewandowski R, Quillin J. Recontacting patients for multigene panel testing in hereditary cancer: Efficacy and insights. J Genet Couns 2019;28:1198-207. [PMID: 31553108 DOI: 10.1002/jgc4.1173] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
2 Mendelsohn BA. Imaging the Whole Genome in Diagnosing Neurologic Disorders. JAMA Neurol 2019;76:1419-20. [PMID: 31589280 DOI: 10.1001/jamaneurol.2019.3117] [Reference Citation Analysis]
3 Reyes KG, Clark C, Gerhart M, Newson AJ, Ormond KE. "I wish that there was more info": characterizing the uncertainty experienced by carriers of pathogenic ATM and/or CHEK2 variants. Fam Cancer 2021. [PMID: 33855648 DOI: 10.1007/s10689-021-00251-3] [Reference Citation Analysis]
4 Brokamp E, Koziura ME, Phillips JA 3rd, Tang LA, Cogan JD, Rives LC, Robertson AK, Duncan L, Bican A, Peterson JF, Newman JH, Hamid R, Bastarache L; Undiagnosed Diseases Network. One is the loneliest number: genotypic matchmaking using the electronic health record. Genet Med 2021. [PMID: 34230636 DOI: 10.1038/s41436-021-01179-w] [Reference Citation Analysis]
5 Halverson CME, Connors LM, Wessinger BC, Clayton EW, Wiesner GL. Patient perspectives on variant reclassification after cancer susceptibility testing. Mol Genet Genomic Med 2020;8:e1275. [PMID: 32329193 DOI: 10.1002/mgg3.1275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 . GfH-Stellungnahme zum Rekontaktieren von Patienten. Medizinische Genetik 2019;31:320-320. [DOI: 10.1007/s11825-019-00256-5] [Reference Citation Analysis]
7 Peltekova I, Buhas D, Stern L, Kirby E, Yusuf A, Elsabbagh M. Enhancing the Impact of Genomics Research in Autism through Integration of Research Results into Routine Care Pathways-A Case Series. J Pers Med 2021;11:755. [PMID: 34442399 DOI: 10.3390/jpm11080755] [Reference Citation Analysis]
8 Winkler EC, Knoppers BM. Ethical challenges of precision cancer medicine. Semin Cancer Biol 2020:S1044-579X(20)30201-7. [PMID: 33045356 DOI: 10.1016/j.semcancer.2020.09.009] [Reference Citation Analysis]
9 Evans BJ, Javitt G, Hall R, Robertson M, Ossorio P, Wolf SM, Morgan T, Clayton EW; LawSeq Quality Task Force. How Can Law and Policy Advance Quality in Genomic Analysis and Interpretation for Clinical Care? J Law Med Ethics 2020;48:44-68. [PMID: 32342785 DOI: 10.1177/1073110520916995] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
10 Chaudhari BP, Manickam K, McBride KL. A pediatric perspective on genomics and prevention in the twenty-first century. Pediatr Res 2020;87:338-44. [PMID: 31578042 DOI: 10.1038/s41390-019-0597-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
11 Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron MS, Martinez MW, Miyake CY, Schaff HV, Semsarian C, Sorajja P. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2020;76:3022-55. [PMID: 33229115 DOI: 10.1016/j.jacc.2020.08.044] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
12 Sobel ME, Dreyfus JC, Dillehay McKillip K, Kolarcik C, Muller WA, Scott MJ, Siegal GP, Wadosky K, O'Leary TJ. Return of Individual Research Results: A Guide for Biomedical Researchers Utilizing Human Biospecimens. Am J Pathol 2020;190:918-33. [PMID: 32201265 DOI: 10.1016/j.ajpath.2020.01.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron MS, Martinez MW, Miyake CY, Schaff HV, Semsarian C, Sorajja P; Writing Committee Members. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2020;142. [DOI: 10.1161/cir.0000000000000937] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
14 Pyeritz RE. Uncertainty in Genomics Impacts Precision Medicine. Trends Genet 2021;37:711-6. [PMID: 33218792 DOI: 10.1016/j.tig.2020.10.010] [Reference Citation Analysis]
15 Austin-Tse CA, Jobanputra V, Perry DL, Bick D, Taft RJ, Venner E, Gibbs RA, Young T, Barnett S, Belmont JW, Boczek N, Chowdhury S, Ellsworth KA, Guha S, Kulkarni S, Marcou C, Meng L, Murdock DR, Rehman AU, Spiteri E, Thomas-Wilson A, Kearney HM, Rehm HL; Medical Genome Initiative*. Best practices for the interpretation and reporting of clinical whole genome sequencing. NPJ Genom Med 2022;7:27. [PMID: 35395838 DOI: 10.1038/s41525-022-00295-z] [Reference Citation Analysis]
16 Ji J, Leung ML, Baker S, Deignan JL, Santani A. Clinical Exome Reanalysis: Current Practice and Beyond. Mol Diagn Ther 2021;25:529-36. [PMID: 34283395 DOI: 10.1007/s40291-021-00541-7] [Reference Citation Analysis]
17 Kanungo S, Barr J, Crutchfield P, Fealko C, Soares N. Ethical Considerations on Pediatric Genetic Testing Results in Electronic Health Records. Appl Clin Inform 2020;11:755-63. [PMID: 33176390 DOI: 10.1055/s-0040-1718753] [Reference Citation Analysis]
18 Haidar CE, Relling MV, Hoffman JM. Preemptively Precise: Returning and Updating Pharmacogenetic Test Results to Realize the Benefits of Preemptive Testing. Clin Pharmacol Ther 2019;106:942-4. [PMID: 31520409 DOI: 10.1002/cpt.1613] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
19 Rego S, Grove ME, Cho MK, Ormond KE. Informed Consent in the Genomics Era. Cold Spring Harb Perspect Med 2020;10:a036582. [PMID: 31570382 DOI: 10.1101/cshperspect.a036582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Richmond CM, James PA, Pantaleo SJ, Chong B, Lunke S, Tan TY, Macciocca I. Clinical and laboratory reporting impact of ACMG-AMP and modified ClinGen variant classification frameworks in MYH7-related cardiomyopathy. Genet Med 2021;23:1108-15. [PMID: 33568804 DOI: 10.1038/s41436-021-01107-y] [Reference Citation Analysis]
21 Fridman AL, Raz A, Timmermans S, Shkedi-Rafid S. Fragmented responsibility: views of Israeli HCPs regarding patient recontact following variant reclassification. J Community Genet 2021. [PMID: 34609721 DOI: 10.1007/s12687-021-00556-x] [Reference Citation Analysis]
22 Castellano S, Cestari F, Faglioni G, Tenedini E, Marino M, Artuso L, Manfredini R, Luppi M, Trenti T, Tagliafico E. iVar, an Interpretation-Oriented Tool to Manage the Update and Revision of Variant Annotation and Classification. Genes (Basel) 2021;12:384. [PMID: 33800487 DOI: 10.3390/genes12030384] [Reference Citation Analysis]
23 Campuzano O, Sarquella-Brugada G, Fernandez-Falgueras A, Coll M, Iglesias A, Ferrer-Costa C, Cesar S, Arbelo E, García-Álvarez A, Jordà P, Toro R, Tiron de Llano C, Grassi S, Oliva A, Brugada J, Brugada R. Reanalysis and reclassification of rare genetic variants associated with inherited arrhythmogenic syndromes. EBioMedicine 2020;54:102732. [PMID: 32268277 DOI: 10.1016/j.ebiom.2020.102732] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
24 Mighton C, Shickh S, Uleryk E, Pechlivanoglou P, Bombard Y. Clinical and psychological outcomes of receiving a variant of uncertain significance from multigene panel testing or genomic sequencing: a systematic review and meta-analysis. Genet Med 2021;23:22-33. [PMID: 32921787 DOI: 10.1038/s41436-020-00957-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
25 David KL, Best RG, Brenman LM, Bush L, Deignan J, Flannery D, Hoffman JD, Holm I, Miller DT, O'Leary J, Pyeritz RE. Response to Knoppers et al. Genet Med 2019;21:2403. [PMID: 30971833 DOI: 10.1038/s41436-019-0496-z] [Reference Citation Analysis]
26 James CA, Syrris P, van Tintelen JP, Calkins H. The role of genetics in cardiovascular disease: arrhythmogenic cardiomyopathy. European Heart Journal 2020;41:1393-400. [DOI: 10.1093/eurheartj/ehaa141] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
27 Richardson B, Fitzgerald-Butt SM, Spoonamore KG, Wetherill L, Helm BM, Breman AM. Management of amended variant classification laboratory reports by genetic counselors in the United States and Canada: An exploratory study. J Genet Couns 2021. [PMID: 34570930 DOI: 10.1002/jgc4.1514] [Reference Citation Analysis]
28 Chowns J, Hoffman-andrews L, Marzolf A, Reza N, Owens AT. Cardiovascular Genetics. Medical Clinics of North America 2022. [DOI: 10.1016/j.mcna.2021.11.007] [Reference Citation Analysis]
29 Rehder C, Bean LJH, Bick D, Chao E, Chung W, Das S, O'Daniel J, Rehm H, Shashi V, Vincent LM; ACMG Laboratory Quality Assurance Committee. Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2021;23:1399-415. [PMID: 33927380 DOI: 10.1038/s41436-021-01139-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
30 Elliott AM. Genetic Counseling and Genome Sequencing in Pediatric Rare Disease. Cold Spring Harb Perspect Med 2020;10:a036632. [PMID: 31501267 DOI: 10.1101/cshperspect.a036632] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 El Mecky J, Johansson L, Plantinga M, Fenwick A, Lucassen A, Dijkhuizen T, van der Hout A, Lyle K, van Langen I. Reinterpretation, reclassification, and its downstream effects: challenges for clinical laboratory geneticists. BMC Med Genomics 2019;12:170. [PMID: 31779608 DOI: 10.1186/s12920-019-0612-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
32 Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron MS, Martinez MW, Miyake CY, Schaff HV, Semsarian C, Sorajja P, O'Gara PT, Beckman JA, Levine GN, Al-Khatib SM, Armbruster A, Birtcher KK, Ciggaroa J, Dixon DL, de Las Fuentes L, Deswal A, Fleisher LA, Gentile F, Goldberger ZD, Gorenek B, Haynes N, Hernandez AF, Hlatky MA, Joglar JA, Jones WS, Marine JE, Mark D, Palaniappan L, Piano MR, Tamis-Holland J, Wijeysundera DN, Woo YJ; Writing Committee Members., ACC/AHA Joint Committee Members. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Thorac Cardiovasc Surg 2021;162:e23-e106. [PMID: 33926766 DOI: 10.1016/j.jtcvs.2021.04.001] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
33 Snir M, Nazareth S, Simmons E, Hayward L, Ashcraft K, Bristow SL, Esplin ED, Aradhya S. Democratizing genomics: Leveraging software to make genetics an integral part of routine care. Am J Med Genet C Semin Med Genet 2021;187:14-27. [PMID: 33296144 DOI: 10.1002/ajmg.c.31866] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Clayton EW, Appelbaum PS, Chung WK, Marchant GE, Roberts JL, Evans BJ. Does the law require reinterpretation and return of revised genomic results? Genet Med 2021;23:833-6. [PMID: 33420344 DOI: 10.1038/s41436-020-01065-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
35 Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron MS, Martinez MW, Miyake CY, Schaff HV, Semsarian C, Sorajja P. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy. Journal of the American College of Cardiology 2020;76:e159-240. [DOI: 10.1016/j.jacc.2020.08.045] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 17.0] [Reference Citation Analysis]
36 Doheny S. Recontacting in medical genetics: the implications of a broadening knowledge base. Hum Genet 2021. [PMID: 34459979 DOI: 10.1007/s00439-021-02353-5] [Reference Citation Analysis]
37 Sarquella-Brugada G, Fernandez-Falgueras A, Cesar S, Arbelo E, Coll M, Perez-Serra A, Puigmulé M, Iglesias A, Alcalde M, Vallverdú-Prats M, Fiol V, Ferrer-Costa C, Del Olmo B, Picó F, Lopez L, García-Alvarez A, Jordà P, Tiron de Llano C, Toro R, Grassi S, Oliva A, Brugada J, Brugada R, Campuzano O. Clinical impact of rare variants associated with inherited channelopathies: a 5-year update. Hum Genet 2021. [PMID: 34546463 DOI: 10.1007/s00439-021-02370-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Deignan JL, Chung WK, Kearney HM, Monaghan KG, Rehder CW, Chao EC; ACMG Laboratory Quality Assurance Committee. Points to consider in the reevaluation and reanalysis of genomic test results: a statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2019;21:1267-70. [PMID: 31015575 DOI: 10.1038/s41436-019-0478-1] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 16.3] [Reference Citation Analysis]
39 Pal T, Agnese D, Daly M, La Spada A, Litton J, Wick M, Klugman S, Esplin ED, Jarvik GP; Professional Practice and Guidelines Committee. Points to consider: is there evidence to support BRCA1/2 and other inherited breast cancer genetic testing for all breast cancer patients? A statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2020;22:681-5. [PMID: 31831881 DOI: 10.1038/s41436-019-0712-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
40 Savatt JM, Azzariti DR, Ledbetter DH, Palen E, Rehm HL, Riggs ER, Martin CL. Recontacting registry participants with genetic updates through GenomeConnect, the ClinGen patient registry. Genet Med 2021. [PMID: 34007001 DOI: 10.1038/s41436-021-01197-8] [Reference Citation Analysis]
41 Davieson CD, Joyce KE, Sharma L, Shovlin CL. DNA variant classification-reconsidering "allele rarity" and "phenotype" criteria in ACMG/AMP guidelines. Eur J Med Genet 2021;64:104312. [PMID: 34411772 DOI: 10.1016/j.ejmg.2021.104312] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
42 Deignan JL, Astbury C, Cutting GR, Del Gaudio D, Gregg AR, Grody WW, Monaghan KG, Richards S; ACMG Laboratory Quality Assurance Committee. CFTR variant testing: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2020;22:1288-95. [PMID: 32404922 DOI: 10.1038/s41436-020-0822-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
43 Giesbertz NAA, van Harten WH, Bredenoord AL. A duty to recontact in genetics: context matters. Nat Rev Genet 2019;20:371-2. [PMID: 30932026 DOI: 10.1038/s41576-019-0121-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
44 Savatt JM, Myers SM. Genetic Testing in Neurodevelopmental Disorders. Front Pediatr 2021;9:526779. [PMID: 33681094 DOI: 10.3389/fped.2021.526779] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
45 Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron MS, Martinez MW, Miyake CY, Schaff HV, Semsarian C, Sorajja P. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2020;142:e533-57. [PMID: 33215938 DOI: 10.1161/CIR.0000000000000938] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
46 Best M, Butow P, Jacobs C, Juraskova I, Savard J, Meiser B, Goldstein D, Ballinger M, Bartley N, Napier C, Davies G, Thomas D, Tucker K, Schlub T, Newson AJ; PiGeOn Project. Advanced cancer patient preferences for receiving molecular profiling results. Psychooncology 2020;29:1533-9. [PMID: 32544291 DOI: 10.1002/pon.5446] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Margolin A, Helm BM, Treat K, Prucka SK, Halverson CME. Assessing parental understanding of variant reclassification in pediatric neurology and developmental pediatrics clinics. J Community Genet 2021;12:663-70. [PMID: 34558037 DOI: 10.1007/s12687-021-00552-1] [Reference Citation Analysis]
48 Halverson CME, Wessinger BC, Clayton EW, Wiesner GL. Patients' willingness to reconsider cancer genetic testing after initially declining: Mention it again. Jrnl of Gene Coun 2019;29:18-24. [DOI: 10.1002/jgc4.1174] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
49 Mighton C, Clausen M, Sebastian A, Muir SM, Shickh S, Baxter NN, Scheer A, Glogowski E, Schrader KA, Thorpe KE, Kim THM, Lerner-Ellis J, Kim RH, Regier DA, Bayoumi AM, Bombard Y. Patient and public preferences for being recontacted with updated genomic results: a mixed methods study. Hum Genet 2021;140:1695-708. [PMID: 34537903 DOI: 10.1007/s00439-021-02366-0] [Reference Citation Analysis]